Doreen J. Addrizzo-Harris, MD, FCCP, is a pulmonary/critical care physician with an extensive background in bronchiectasis and non-tuberculous mycobacterial infection and medical education. Dr. Addrizzo-Harris is currently a Professor of Medicine at the NYU Grossman School of Medicine. She serves as the Associate Division Director for Clinical and Faculty Affairs, is the Director of the NYU Bronchiectasis and NTM Program, and is Co-Director of the NYU Pulmonary Faculty Practice. She is now serving in her 20th year as the Program Director of NYU’s Pulmonary and Critical Care Medicine Fellowship.
Dr. Addrizzo-Harris received her medical degree and completed her residency and fellowship training at New York University School of Medicine. Since completing her training, she was recruited to stay as a faculty member at NYU, where she has been a critical presence over the past 25 years. She has been instrumental in educating the next generation of pulmonary/critical care physicians and has won a number of awards for her teaching skills, most recently, the 2020 first place Program Director of the ATS Best Practice Program. Dr. Addrizzo-Harris has served on the board of the Association of Pulmonary and Critical Care Medicine Program Directors (APCCMPD), including serving as President from 2006-2007. Academically she authored 39 peer-reviewed publications and 54 scientific abstracts presented at international conferences. She has participated in numerous clinical trials, many as PI. Dr. Addrizzo-Harris has been recognized as a Distinguished CHEST Educator each year since its inception since 2017 and received the Distinguished Service Award in 2019.
During her leadership tenure with CHEST, Dr. Addrizzo-Harris has served on the Marketing Committee, the Health and Science Policy Committee (Chair from 2007-2009), Government Relations Committee, Scientific Program Committee, Education Committee, Governance Committee, Editorial Board for CHEST Physician, Professional Standards Committee (Chair 2016-2018), Board of Regents, and CHEST Foundation Board of Trustees. Most recently, Dr. Addrizzo-Harris served as the President of the CHEST Foundation from 2018-2019 and Co-Chair of the Foundation Awards Committee from 2015-2020. Dr. Addrizzo-Harris will serve as the sixth women to lead the American College of Chest Physicians.
Dr. Sita Andarini is currently academic staff and Consultant at Division of Thoracic Oncology and Division of Respiratory Immunology and Interstitial Lung Disease, Department of Pulmonology and Respiratory Medicine, Faculty of Medicine University of Indonesia – Persahabatan Hospital. After completing her MD and Pulmonologist at Faculty of Medicine University of Indonesia, she obtained PhD in Tohoku University, Japan. She is currently head of Thoracic Oncology Indonesian Society of Respirology, Head of Assembly of Lung Cancer for Asian Pacific Society of Respirology, and member of International Association for the Study of Lung Cancer. Her interest includes thoracic oncology especially immuno-oncology and driver oncogene, and interstitial lung diseases. She involves in several clinical research of lung cancer and interstitial lung disease. She published several papers, receiving research grants and awards in lung cancer and interstitial lung disease.
Dr. Balmes is Professor of Medicine Emeritus at the University of California, San Francisco (UCSF) and Professor of Environmental Health Sciences Emeritus in the School of Public Health at the University of California, Berkeley (UC Berkeley). He is an Attending Physician in the UCSF Division of Occupational, Environmental and Climate Medicine and the Division of Pulmonary and Critical Care Medicine at the Zuckerberg San Francisco General Hospital. At UC Berkeley, he is one of the Principal Investigators of the Children’s Health and Air Pollution Study (CHAPS) in Fresno, California. Dr. Balmes has been studying the effects of occupational and environmental agents on respiratory, cardiovascular, and metabolic health for over 40 years. He was appointed Physician Member of the California Air Resources Board in 2008.
Phil Bardin is Professor of Respiratory Medicine in the Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia. Since 2008 he has been Director, Lung Sleep Allergy & Immunology, Monash University and Medical Centre, Melbourne.
He is recognised for investigation of obstructive lung diseases (particularly virus-asthma-COPD exacerbations) and has conducted extensive research of new asthma and COPD therapies. Recently research has also focussed on vocal cord dysfunction in obstructive lung diseases. He is a recipient of ongoing Australian NH&MRC funding, has chaired the Australian NH&MRC Grant Review Panel (Respiratory & Sleep Medicine) and served on the Australian NH&MRC Academy. His professional activities reflect a career-long commitment to research and medical education, particularly in the areas of asthma and COPD.
Currently he is co-Editor-in-Chief of Respirology, official journal of the TSANZ and APSR.
Dr Imran Bin Mohamed Noor
Lead Pleural Physician
Changi General Hospital
Dr Imran Bin Mohamed Noor graduated from the National University of Singapore, Faculty of Medicine in 1998. He obtained his MRCP in 2003. He completed his 3-year training in Respiratory Medicine in 2007. In 2010, he did a one year fellowship under the HMDP programme in Sir Charles Gairdner Hospital. This included a 6-month training in pleural diseases under the guidance of Prof Gary Lee. Upon completion of his fellowship, Dr Imran has been pivotal in the establishment of a pleural service in Changi General Hospital. The service oversees the management of pleural disease within the hospital, from pneumothorax to pleural effusions. This include inpatient services as well as outpatient services like pleural clinic and post-discharge community service for patients with indwelling pleural catheter. He currently serves as the lead pleural physician for the Department of Respiratory & Critical Care Medicine in Changi General Hospital.
Pr. Laurent Brochard is Intensivist, Clinician Scientist, St. Michael’s Hospital (Unity Health Toronto) and Director of the Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada, since 2014. He holds the Keenan Chair in Critical Care and Acute Respiratory failure.
He trained in respirology and critical care, obtained his MD degree, University of Paris, and worked in Assistance Publique-Hôpitaux de Paris (Hôpital Henri Mondor, Creteil) until he moved to Geneva University Hospital, Switzerland (2010-2013) before being recruited in Toronto.
He has been Editor-in-Chief of Intensive Care Medicine, is currently Deputy Editor of the American Journal of Respiratory and Critical Care Medicine.
He created a clinical research network on mechanical ventilation REVA. He leads an international group on respiratory physiology (PLUG) and leads the Centre of Excellence in Mechanical Ventilation in Toronto (CoEMV).
He mentored and directed numerous trainees, many of whom are leaders in Critical Care. He published over > 700 peer-reviewed publications (H-index 123).
Dr. Louis Chai is Senior Consultant Infectious Diseases Physician and Associate Professor in the Department of Medicine, National University Health System, Singapore, as well as Principal Investigator, Opportunistic Infections Group, Division of Infectious Diseases, NUHS. Dr Chai’s interests lie in fungal, opportunistic and atypical infections in immunocompromised hosts, patients with altered immunity and host-pathogen interaction. These are also the themes of his research group. He remains deeply entrenched at the bedside in providing clinical service for general infectious diseases and internal medicine. Dr Chai is funded by the National Medical Research Council of Singapore and the National University Health System.
Professor James D Chalmers is Asthma and Lung UK Chair of Respiratory Research at the University of Dundee and a Consultant Respiratory Physician. His clinical and research interests are in difficult respiratory infections, particularly bronchiectasis, COPD and COVID-19. His research group is particularly focused on novel non-antibiotic approaches to treating chronic lung inflammation, and he leads several international trials of novel therapeutics. He is chair of the Science and Research Committee of the British Thoracic Society and is Chief editor of the European Respiratory Journal. He has chaired multiple international guidelines and is current chair of the European Bronchiectasis Registry.
Dr Chan Kwok Wai Adrian is a consultant respiratory physician, allergy specialist and intensivist at Mount Elizabeth Novena Hospital. Dr Chan is actively involved in various professional committees, including secretary and executive committee member for the Singapore Thoracic Society, as well as executive committee member for the Allergy and Clinical Immunology Society of Singapore. He is also the current president of the Asthma and Allergy Association of Singapore.
Dr Amy Chan is senior clinical academic at the University of Auckland, New Zealand, working clinically in primary care. Amy also holds an honorary post at the Centre of Behavioural Medicine, University College London, UK and is affiliated with the Asthma UK Centre of Applied Research. For over 15 years, Amy has been conducting research into the intersection between adherence, digital technologies and asthma management, including how technologies can be used to promote medication adherence and improve asthma outcomes using big data and innovative technologies. Amy has experience applying her research to improve asthma care through providing consultancy to charities, medical research organisations, and non-government organisations. Amy is the global lead for workforce transformation with the International Pharmaceutical Federation (FIP), working group lead for the European Respiratory Society Clinical Research Collaboration CONNECT, and member of the Respiratory Effectiveness Group, Open Digital Health, PSA Respiratory Taskforce and Asthma NZ board.
Dr Chee graduated from the National University of Singapore (NUS) in 1984. She obtained the Membership of the Royal College of Physicians (Edinburgh), and Masters of Medicine (Internal Medicine) from the School of Postgraduate Medicine, NUS in 1989. She trained as an adult Respiratory Physician and was granted the Fellowship of the Royal College of Physicians (Edinburgh) in 1999. She was involved in the setting up of the Ministry of Health Singapore TB Elimination Programme (STEP) in 1997 and in implementing its initiatives for over twenty years. She was Director of STEP and the TB Control Unit from January 2018 to September 2019. She has published over 100 articles in medical peer-reviewed journals.
Professor Chen is a full Professor and attending physician of Chang Gung University and Chang Gung Memorial Hospital, Taiwan. He was trained in sleep medicine at Stanford Sleep Disorders Clinic and the Division of sleep medicine, Center for Sleep and Respiratory Neurobiology-CSRN in Philadelphia.
Dr. Chen was the founder of Sleep Center in Chang Gung Memorial Hospital. He has served as the 3rd President of Taiwan Society of Sleep Medicine, Secretary General of World Sleep Federation, Vice President of Asian Sleep Research Society, President of Asian Society of Sleep Medicine and now the head of the Assembly of Neurobiology and Sleep of APSR.
Dr. Chen published more than 180 SCI articles, two books, and owns several patents about sleep. He won the Fukuchi Award of APSR in 2018 and was named as world’s top 2% Scientists jointly published by Elsevier BV and Stanford University in 2020 and 2021.
Dr Cheong May Anne is a Consultant in the Department of Haematology, Singapore General Hospital. She received the NUS Undergraduate (Merit) Scholarship to read Medicine at the National University of Singapore and graduated in 2012. She completed her Internal Medicine training at Singhealth in 2017, where she served as Chief Resident. She completed specialist training in Haematology at Singhealth in 2020 and obtained her FRCPath (Haematology) in 2019. May Anne has a subspeciality interest in thrombosis and haemostasis and leads the cancer associated thrombosis service at the National Cancer Centre, Singapore and a founding member of the pulmonary embolism response team at Singapore General Hospital.
Dr CHEW Fook Tim is Vice Dean of the Faculty of Science, National University of Singapore (NUS), overseeing the Undergraduate and International Programs. He also oversees the Curriculum of the combined College of Humanities and Sciences (CHS) at NUS. He is also an Associate Professor at the Department of Biological Sciences teaching both Undergraduate and Postgraduate Molecular Genetics and Immunology; and is the Principal Investigator of the Functional Genomics Laboratories, Molecular Immunology and Allergy Lab, and the Molecular Breeding Lab at the NUS Agritech Centre. His key areas of research are in the Genetics and Epidemiology of Allergic and Skin Diseases, as well as the Characterization of Allergenic Components, where he has published >200 scientific articles and reviews. He is the lead scientific consultant to Biomedical and Agri-Science companies and is on the Governing Board of several major organizations.
Dr Chia Puey Ling is a Medical Oncology Consultant at Tan Tock Seng Hospital with subspecialty interest in thoracic and genitourinary oncology.
After completing her basic physician training in Singapore and obtaining membership of the Royal Colleges of Physicians of the United Kingdom (MRCP) and Master of Medicine (Int. Med) Singapore, she subsequently underwent advanced specialist training in Medical Oncology in Melbourne, Australia. She obtained the fellowship of the Royal Australasian College of Physicians (FRACP) with specialty training in Medical oncology completed in 2014 and went on to pursue further PhD research related to thoracic oncology which is her field of interest.
She received the International Association for the Study of Lung Cancer (IASLC) Fellowship Award and the University of Melbourne Postgraduate Award and completed a PhD research on the study of tumour microenvironment and biomarkers in malignant mesothelioma for oncogenic targeted therapies.
She is the principle investigator or co-investigator for several international multi-centre cancer clinical trials including novel immunotherapy, targeted agents and drugs in early phase development. She has also published numerous first-author papers, including the Journal of the National Cancer Institute (JNCI) and Lung Cancer Journal.
A/Prof. Naricha Chirakalwasan is an Associate Professor of Medicine at Division of Pulmonary and Critical Care medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University and Program Director of International Sleep Medicine Fellowship.
She also holds the position of Associate Dean of International Affairs, Faculty of Medicine, Chulalongkorn University.
She is a quadruple American Boards certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine, and Sleep Medicine.
A/Prof. Naricha Chirakalwasan has published extensively in original articles as well as review articles in well recognized journals and authored several book chapters in international textbooks.
She was an organizing chairman of the 2nd ASEAN Sleep Congress conducted in Bangkok, Thailand in August 2013, and a Scientific Co-Chair of Asian Pacific Society of Respirology (APSR) Congress conducted in Bangkok, Thailand in November 2016. She is a current Secretary-General for Federation of South East Asian Sleep Medicine (FSSM) and appointed for the position of Head-Elect for Respiratory Neurobiology and Sleep Assembly of APSR.
She also received an award of “Outstanding Young Physician” in 2021 by the Royal College of Physicians of Thailand.
Dr Choo Xue Ning is a Senior Consultant in the Department of Respiratory & Critical Care Medicine at Changi General Hospital. She has a Bachelor of Medicine and Surgery (M.B.B.S) and Master of Medicine (Internal Medicine) from National University of Singapore. She has been a Member of Royal Colleges of Physicians of the United Kingdom since 2010 and has been awarded Certificate of Specialist Registration in Respiratory Medicine since 2014. She is also a fellow of the Royal College of Physicians of Edinburgh since December 2021.
She has a special interest in Respiratory Medicine in airway diseases (such as asthma, COPD etc). Additionally, she has a profound interest in respiratory function and physiology and has been Director of Pulmonary Function Laboratory at Changi General Hospital since 2017. She had previously undergone a 1-year fellowship training in airway diseases and advanced lung function at the Oxford University Hospitals, United Kingdom.
ASSOCIATE PROFESSOR SANJAY H CHOTIRMALL Provost’s Chair in Molecular Medicine and Assistant Dean (Research), Lee Kong Chian School of Medicine, NTU Singapore Consultant Respiratory Physician, Tan Tock Seng Hospital, Singapore
A/Prof Chotirmall is an internationally recognized clinician-scientist with an established translational respiratory research group at the Lee Kong Chian School of Medicine, NTU Singapore. To date, he has performed key work on endo-phenotyping pulmonary infection, including the use of next generation sequencing approaches to study the lung microbiome, in the context of chronic inflammatory respiratory diseases that have led to publications in Nature Medicine, the New England Journal of Medicine (NEJM), the Lancet Respiratory Medicine, Cell Host and Microbe and the American Journal of Respiratory and Critical Care Medicine (AJRCCM). He has been appointed Provost’s Chair in Molecular Medicine at NTU Singapore since 2019 and currently serves as Deputy Editor at the American Journal of Respiratory and Critical Care Medicine (AJRCCM).
Matthew Cove completed an Internal Medicine Residency in Portland Oregon and a Critical Care Fellowship in Pittsburgh. He moved to Singapore in 2012, where he works as a Critical Care Consultant. His clinical appointment includes providing consultant cover in the Medical Intensive Care and Surgical High Dependency Units at National University Hospital Singapore. His research interests include the development of novel extracorporeal ventilation support devices and patient-ventilator interactions, particularly in those with acute respiratory distress syndrome. Since arriving in Singapore, Matthew has received funding from the National Medical Research Council to develop a research lab focused on extracorporeal respiratory support research as well as conduct clinical trials. In addition, his clinical research team are currently participating in a large international study (REMAP CAP), investigating the best treatment options for critically ill patients with pneumonia and has funding for developing novel diagnostics for fever and sepsis.
Charles L. Daley, M.D., is Chief of the Division of Mycobacterial and Respiratory Infections at National Jewish Health (NJH) and Professor of Medicine at NJH, the University of Colorado, and Icahn School of Medicine at Mount Sinai. Prior to coming to NJH, he was medical director of the Curry Training Center at the University of California, San Francisco. Dr. Daley has served on and chaired expert panels for the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Infectious Diseases Society of America and American Thoracic Society. He Chaired the revision of the multi-society sponsored NTM Treatment Guideline. Dr. Daley chaired the Green Light Committee, gGLC, and Global Drug Resistance Initiative (GDI) for the Stop TB Partnership and World Health Organization. For his work with MDR-TB he was awarded the World Lung Health Award by the American Thoracic Society. He was previously Associate Editor of the American Journal of Respiratory and Critical Care Medicine and The European Respiratory Journal and is now Associate Editor of Frontiers in Tuberculosis. His academic interests include TB global health policy and clinical and translational research related to TB, NTM infections and bronchiectasis.
Associate Professor Anantham Devanand is the head of the SingHealth Duke-NUS Lung Centre.
He also has an interest in medical ethics and is serving as the vice chair of the Singapore National Medical Ethics Committee. Devanand is also a part-time PhD student at the NUS Centre for Biomedical Ethics, Yong Loo Lin School of Medicine.
Yvonne C. Fenelus began her career as a Critical Care Respiratory Therapist at the National University Hospital in 2017, following completion of her undergraduate studies in Respiratory Therapy. Serving as a clinical educator, she has been actively involved in imparting respiratory care expertise to fellow healthcare professionals on topics including high flow oxygen therapy, tracheostomy management, and mechanical ventilation. As an active member of the Association of Respiratory Therapists (Singapore), she has organised several in-services to foster knowledge exchange and collaboration within the healthcare community. Currently, she leads a team of 22 Respiratory Therapists within her workplace and is pursuing her master’s degree in public health.
Professor Dale Fisher is an Australian infectious diseases physician who first moved to the National University Hospital, Singapore in March 2003 during the SARS outbreak. He has had many leadership roles in international outbreak missions and outbreak response trainings in African and Asian countries. He was chair of the steering committee of WHO’s Global Outbreak Alert & Response Network (2018-2022). He was one of 12 international technical experts on the WHO mission to China in February 2020 to investigate the COVID-19 outbreak. In 2022, he was given a certificate for outstanding leadership by the Director General of WHO.
He is Group chief of Medicine at National University Health Systems and is the foundation chair of the National Infection Prevention and Control Committee (2014 – ongoing). He has authored over 200 peer-reviewed publications and given almost 200 invited and plenary presentations at academic meetings and conferences.
Monika Gappa is Professor of Paediatrics and Director of the Children’s Hospital, Evangelisches Krankenhaus Düsseldorf. She is the current President of the European Respiratory Society (ERS). Her main areas of interest are paediatric respiratory physiology, particularly assessment of lung function, early origins of lung disease, severe asthma, and allergy. She has been Associate Editor of Paediatric Pulmonology for many years and is on the Editorial Board of a number of respiratory journals. She has been active member of the ERS for more than 30 years, has contributed to a number of Task Forces and led the paediatric HERMES program. In 2020, she received the ERS Educational Award.
Medicine Degree at Universitat de Barcelona (1996) and Doctor in Public Health and Methodology of the Biomedical Research by the Universitat Autònoma de Barcelona (2002). Her research focuses on determinants of chronic respiratory disease (asthma and chronic obstructive pulmonary disease (COPD)) development and prognosis in children and adults, the definition and subtype characterization of these conditions and the use of advanced epidemiological methods (machine learning, causal methods).
She has conducted pioneering research on the role of physical activity in asthma and COPD, which merited several national and international awards, and is the coordinator of large multicentre national and international studies in respiratory epidemiology.
She has published more than 140 peer-reviewed scientific papers, and has served in several expert committees tasked with developing international policies on pulmonary rehabilitation and in national research evaluation committees.
She has ongoing close collaborations and projects with European researchers on physical activity and pulmonary rehabilitation as well as strategic alliances with
researchers from the Harvard School of Public Health (Boston, USA), the Epidemiology, Biostatistics and Prevention Institute (Zurich, Switzerland) and the Institut National de la Santé et de la Recherche Médicale (INSERM, France) in the areas of COPD and asthma epidemiology, as well as epidemiological methods.
A/Prof. Ruowen Ge
Associate Professor, Department of Biological Sciences, National University of Singapore
Ruowen Ge is a molecular cell biologist with more than 30 years’ experiences in biomedical research. Her research focuses on novel endogenous anti-angiogenesis and anti-inflammation proteins, investigating their biological mechanisms as well as therapeutic applications. She has published around 100 peer-reviewed papers, applied for 9 patents (3 of which have been awarded). Her lab is the first to identify ISM1 as an anti-angiogenic/anti-cancer protein and subsequently as an anti-inflammation protein critical for protecting lung homeostasis. She currently serves on the editorial board of BMC Respiratory Medicine, Cancers, Discover Oncology, and Scientific Reports. Her research has facilitated the establishment of two biopharma startup companies.
Clinical Professor Anne Goh Senior Consultant, Paediatric Respiratory Medicine Service and Allergy Service
Department of Paediatrics
KK Women’s and Children’s Hospital
She is the current President of the Asian Paediatric Pulmonology Society as well as the Assembly Head of the Paediatric Lung Disease Assembly of the Asia-Pacific Society of Respirology. She was the past President of the Singapore Paediatric Society from 2011-2020. She is a Clinical Professor of Duke-NUS Graduate Medical School and Associate Professor of the Lee Kong Chian School of Medicine and Yong Loo Lin School of Medicine. She is a reviewer for many international journals in Respiratory and Allergy as well as for the NMRC Exploratory and Developmental proposals.
She has clinical and research interests in respiratory and allergy and has authored several peer-reviewed papers as well as given many presentations at national and international courses and conferences.
Associate Professor Denise Goh obtained her medical degree (MBBS Honours) from NUS in 1993. She received her general paediatrics training at NUH from 1994 to 1996 and graduated in 1996 with two postgraduate degrees in paediatrics (Masters of Medicine in Paediatrics and Membership of the Royal College of Physicians). In 1999, she went on to do a 3-year Post-Doctoral Fellowship in Medical Genetics at Johns Hopkins University, USA. In 2002, she obtained her board certification in biochemical genetics and became a Fellow of the American College of Medical Genetics and a diplomate of the American Board of Medical Genetics. She obtained her Doctorate in Medicine in 2002, and is a Fellow of the Academy of Singapore.
A/Prof Goh is an Associate Professor at NUS. She is the chair of the Faculty Assessment committee, Paediatric Undergraduate Medical Director and the genetics module leader for the NUS Yong Loo Lin School of Medicine. She is the co-editor of the textbook Paediatric differential diagnosis – Top 50 problems.
A/Prof Goh currently practises as a Senior Consultant. She is a paediatrician and heads the specialised clinical genetic service that provides dedicated and holistic care to children and adults with or at risk of genetic disorders. She is involved in helping patients who are in need of financial assistance – she is the Chairman of the NUH Children’s Fund and a member of the NUH Children’s Liver & Rare Diseases Fund.
A/Prof Goh provides genetic expertise to other organisations such as the Ministry of Health.
Her research areas include the diagnosis and management of genetic conditions.
Professor Dr. Gerhard Grüber is a Full Professor at the School of Biological Sciences, Nanyang Technological University, Singapore. He obtained his PhD (Dr. rer. nat.) in Biochemistry from the Johannes Gutenberg-University Mainz, Germany, received his postdoctoral training as a DAAD-fellow in Biochemistry and Structural Biology at University of Oregon, USA and obtained as a DFG Habilitation Fellow his PhD (Dr.-habil.) at University of Osnabrück, Germany. He led the Tuberculosis excellence cluster TOPNet and is leading the Nontuberculous Mycobacteria excellence cluster TELMabNet. He is interest in relationships between the structure and mechanism(s) of mycobacterial enzymes related to bioenergetics, stress response and coenzyme A biosynthesis and of the pathogen Acinetobacter baumannii. His team uses a variety of structural, biochemical and biophysical approaches, paving the way for new structures, -targets, novel or improved inhibitors and lead compounds. He holds patents on novel anti-TB and anti-Mab targets and inhibitors targeting the mycobacterial F-ATP synthase.
Professor Graham Hall Director, Synergy Health Solutions
Professor, Curtin University
Honorary Research Associate, Telethon Kids Institute
Professor Graham Hall is respiratory physiologist with an interest in the translation of research outcomes into clinical practice, in particular newer respiratory function tests in the identification of early onset lung disease to improve the diagnosis and management of respiratory disease in children. Graham was the Co-chair of the Global Lung Function Initiative for a number of years and heavily engaged in the implementation of new reference ranges into clinical practice.
Prof Hall is the Managing Director of Synergy Health Solutions, holds an Honorary Research Associate appointment at Telethon Kids and is an adjunct Professor at Curtin University.
Professor Halpin is Consultant Physician & Honorary Professor in Respiratory Medicine at the University of Exeter. He was appointed as a Consultant in 1994. He has a busy clinical practice and for 13 years he was Clinical Lead for the Department in Exeter, overseeing the growth in its clinical and research activity. He is also Honorary Professor of Respiratory Medicine at the Observational and Pragmatic Research Institute (OPRI) in Singapore.
He is a member of the Board of Directors of the Global Initiative on Obstructive Lung Diseases (GOLD) and of the GOLD Science Committee. He was the Chairman and Clinical Expert for the COPD Guideline Development Group of the National Institute of Clinical Excellence (NICE) in the UK.
He studied at Oxford University (first class honours) & St Thomas Hospital Medical School, qualifying in 1986. He was awarded an MRC scholarship to undertake a D.Phil. in the Department of Human Anatomy at Oxford University, between his pre-clinical and clinical training. He trained in respiratory medicine at the Brompton Hospital in London.
He is a Fellow of Royal College Physicians, and a Member of the BTS, ERS & ATS.
He has served on various BTS committees.
In 2018 he was elected as a Fellow of ERS in recognition of lifetime excellence and contributions to research, education and clinical leadership in respiratory medicine.
His research is focussed on clinical aspects of COPD and asthma. He has published extensively and frequently gives presentations on COPD and asthma at lectures and meetings around the world. He was an Associate Editor of Thorax and is on the editorial board of American Journal of Respiratory & Critical Care Medicine as well as several other journals and is a peer reviewer for many others.
Toyohiro Hirai is Professor and Chair, Department of Respiratory Medicine, Graduate School of Medicine Kyoto University, and is also deputy director of Kyoto University Hospital, Japan. He has been Chairman of the Board of Directors of the Japanese Respiratory Society since 2022. He is a respiratory physician, specializing especially in pulmonary physiology and structure-function relationships in his research.
Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University and Alfred Health in Melbourne, Australia. She leads a research program that aims to improve the lives of people with chronic lung disease using non-pharmacological treatments. Her recent clinical trials have tested novel models of pulmonary rehabilitation to improve access and uptake, including low cost home-based models and telerehabilitation. Professor Holland has published over 380 peer reviewed journal articles and her publications have been cited over 25 000 times. She was co-chair and senior author for the recently published Clinical Practice Guidelines on Pulmonary Rehabilitation from the American Thoracic Society . Professor Holland is currently the President of the Thoracic Society of Australia and New Zealand.
Jay Horvat is a Professor of Immunology and Microbiology and Deputy Head of School of Biomedical Sciences and Pharmacy (Research) at the University of Newcastle and Hunter Medical Research Institute. He leads a team that specialises in the development of the most highly representative animal and cell models of many infection & inflammation-induced diseases. In combination with complementary clinical investigations, his team have used their unique models to make major advances in understanding mechanisms of pathogenesis of respiratory and reproductive tract diseases and identify novel therapies. One of his research interests includes understanding how the inter-relationship between immunity and iron metabolism affects the pathogenesis and susceptibility to infection in lung diseases such as asthma, COPD and IPF.
Dr. Yoshikazu Inoue, M.D., Ph.D. Osaka Anti-Tuberculosis Association, Osaka Fukujuji Hospital, Osaka, Japan, advisor
National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan, visiting researcher
Dr. Yoshikazu Inoue is a world-renowned pulmonologist and researcher, who is expert in Interstitial Lung diseases(ILD) and rare lung diseases such as pulmonary alveolar proteinosis(PAP), lymphangioleiomyomatosis(LAM)). From 1994 to 1997, he studied granulomatous lung diseases and pulmonary fibrosis at National Jewish Center for Immunology and Respiratory Medicine in Denver, Colorado. From 1997, he has worked in National Hospital Organization(NHO) Kinki-Chuo Chest Medical Center, Osaka, Japan. From 2011, he was an Invited Professor, Infection, Immunology and Oncology Cooperating Course, Graduate School of Medicine, Osaka University. From 2014, he was a group leader of the NHO Respiratory Network. From 2023, in addition to NHO Kinki-Chuo Chest Medical Center, he started to work in the Osaka Anti-Tuberculosis Association Osaka Fukujuji Hospital, as an advisor. He has conducted or collaborated many international/domestic official guidelines, global clinical trials, and international/domestic multicenter studies. He also has served patient societies of LAM, PAP and ILD.
Dr. Takashi Iwanaga graduated from Kindai University and obtained Doctor of Medicine in 1990, and was received Ph. D. in 1996. He studied clinic and conducted research in the field of respiratory medicine and allergy at the Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine (1990~2021). He studied abroad at the Department of Respiratory Cell and Molecular Biology, Southampton General Hospital, University of Southampton (Prof. Stephen T Holgate) (2000-2002). Currently, He is a professor at Kindai University Hospital and director of the Center for General Medical Education and Training. He served as a member of the committee for Japanese Guidelines for Asthma Prevention and Management (2015, 2018), Management of Refractory Asthma (2019, 2023) and the Allergen Immunotherapy (2022). Since 2021, he has served as Head of the Clinical Allergy and Immunology Assembly of the Asia-Pacific Respiratory Society.
Dr. Hojoong Kim is Professor of Medicine at Sungkyunkwan University School of Medicine and Samsung Medical Center. Dr. Kim is a member of the Korean Medical Association, the Korean Society of Tuberculosis and Pulmonary Disease, as well as a member of international organizations such as the International Association for the Study of Lung Cancer, World Association for Bronchology, and the Asian Pacific Association for Bronchology. Although a major focus of his research and clinical activity has been in the field of Bronchology, Lung Cancer and Pulmonary Hypertension, Dr. Kim has also considerable expertise in IRB, Human Research Protection Plan and Safety issues in hospital management. Dr. Kim was appointed as a Congress President of 5th APCB held in Seoul, Korea at 2013.
2000.3 – 2006.2 M.D. College of Medicine, CHA University
2008.3 – 2010.2 M.S. College of Medicine, Graduate School, CHA University
2010.3 – 2017.2 Ph.D College of Medicine, Graduate School, CHA University
2006.3-2007.2 Internship in Bundang CHA Hospital
2007.3-2011.2 Residency in Department of Internal Medicine in Bundang CHA Hospital
2011.3-2012.5 Fellowship of Pulmonary and Critical care medicine in Asan Medical Center
2012.6-2014.2 Fellowship of Allergy and Clinical Immunology, in Ajou University hospital
2014.3-2022.2 Assistant Professor, Department of Pulmonology, Allergy and Critical care medicine, CHA Bundang Medical Center, CHA University
2022.3-present Associate Professor, Department of Pulmonology, Allergy and Critical care medicine, CHA Bundang Medical Center, CHA University
Woo Jin Kim is Professor of Internal Medicine and Chief of Environmental Health Center of Kangwon National University Hospital in Korea. He graduated from Seoul National University of Korea, College of Medicine. He has main research interest in COPD and environmental lung health issues, particularly genetic, environmental and epigenetic effects on chronic respiratory disease. He is a member of Korean Academy of Tuberculosis and Respiratory Disease and American Thoracic Society and also serves as head of Environmental, Occupational Health and Epidemiology assembly of Asia-Pacific Society of Respirology. He works as an associate editor for Tuberculosis and Respiratory Disease and BMC Pulm Med.
Professor Greg King is a staff specialist in the Department of Respiratory Medicine at Royal North Shore Hospital, Medical Director of the Respiratory Investigation Unit, and Research Leader of the Airway Physiology and Imaging Group at the Woolcock Institute of Medical Research. He is Conjoint Professor of Respiratory Medicine at the Northern Clinical School of the University of Sydney. He currently supervises PhD and other postgraduate students and uses complex lung function tests and imaging to study lung physiology and mechanics in airways diseases.
Dr Fanny Wai San Ko Consultant, Department of Medicine and Therapeutics, Prince of Wales Hospital Hong Kong
Honorary clinical associate professor, Department of Medicine and Therapeutics, The Chinese University of Hong Kong
Dr Ko is a specialist respiratory consultant physician in the Department of Medicine and Therapeutics at Prince of Wales Hospital in Hong Kong and the Honorary Clinical Associate Professor of the Faculty of Medicine of the Chinese University of Hong Kong.
Dr Ko’s main research interest is in asthma and COPD and has published more than 180 papers in peer-reviewed journals. She was elected as the Fellow of the European Respiratory Society in 2022. She was also a recipient of the Croucher Foundation Scholarship and Hong Kong Lung Foundation Fellowship.
Dr Ko is currently a member of the Scientific Committee of the Global Initiative for Asthma (GINA), Chairman of Hong Kong Lung Foundation, Senior Editor of Respirology and Medical Advisor of the Hong Kong Asthma Society. In addition, she is a Past President of the Hong Kong Thoracic Society and past Vice-President of the Hong Kong Institute of Allergy.
Dr. Jansen Koh obtained his MBBS from the National University Hospital of Singapore in 2001. He Obtained his MRCP (UK) in 2007 and EDIC in 2010. He is currently the Head of Department for Respiratory & Critical care Medicine Changi General Hospital. He is also the Deputy Head and Service Chief @CGH, Singhealth-Duke NUS Lung Center. He leads the Center for Performance Excellence Department in his capacity as Assistant Chairman Medical Board, Changi General Hospital. He is also the Chair for the Respiratory Chapter, College of Physicians, Academy of Medicine, Singapore. His specific interest in Respiratory & Critical Care is point of care ultrasonography, having obtained his certification from the American College of Chest Physicians. He is a Fellow at the Academy of Medicine Singapore, Royal College of Physicians Edinburgh and American College of Chest Physicians.
Associate Professor Mariko Siyue Koh (MBBS, MRCP, FAMS)
Senior Consultant in the Department of Respiratory and Critical Care Medicine, Singapore General Hospital ( SGH)
Clinical Associate Professor, Duke- National University Singapore, Singapore
A/Prof Koh ‘s clinical and research interest are in Severe Asthma and Airway diseases. She established the multidisciplinary Singapore General Hospital Severe Asthma Clinic in 2011 and leads a team of doctors, nurses, pharmacists, and other allied health professionals in the SGH Airway Diseases Program. She is also active in various Ministry of Health and Asthma committees, has academic collaborations from various institutions and universities, has >100 publications and sits in editorial boards of a few journals.
Dr Gillianne Lai is a Consultant Medical Oncologist at the National Cancer Centre Singapore. She received her undergraduate training from the Yong Loo Lin School of Medicine, National University of Singapore and is a member of the Royal College of Physicians of the United Kingdom. She completed her Medical Oncology specialty training at the National Cancer Centre Singapore. She has a strong interest in thoracic oncology and is actively involved in research. She currently leads that Lung Cancer Consortium Singapore (LCCS), and is the Principal Investigator of the National Lung Cancer Research (NLCR) study which aims to improve lung cancer care through 4 main themes: (1) understanding the origins of lung cancer, (2) improving risk stratification of disease, (3) identifying better response biomarkers, and (4) understanding resistance mechanisms. She is also the chairperson of the Singhealth Lung Centre Pulmonary Nodule Workgroup and has a keen interest in lung cancer screening.
Dr Lam is Clinical Associate Professor, Chief of Division of Respiratory Medicine, and Deputy Chief of Service of the Department of Medicine, HKU.
He is a respiratory physician with research interests in lung cancer, COPD, smoking and airway physiology. He performs endobronchial ultrasonography and autofluorescence imaging for early detection of lung cancer. He established a lung nodule program to complement lung screening study.
He is on the International Lung Screening Trial Consortium, steering multi-centered lung screening research. In his laboratory, new lung cancer cell lines and organoids serve as models for research in lung cancer.
He is the President of APSR and President of the Forum of International Respiratory Societies (FIRS).
He is Deputy Editor of Respirology and Associate Editor of Respirology Case Report; Honorary Secretary of Hong Kong Lung Foundation (HKLF); and Co-Chairperson of the East Asian Lung Cancer Screening Alliance.
He received multiple research awards including the Tohoku Medical Society Medal (2019), the APSR Woolcock Research Award (2021), and HKLF Donald Yu Lecture (2023).
Thérèse Lapperre is an Associate Professor in Respiratory Medicine at the University of Antwerp and head of the department of Respiratory Medicine at the Antwerp University Hospital (UZA). She has an international background, being trained in the Netherlands (Leiden University) and having worked as a pulmonologist and researcher in both Singapore (Singapore Genral Hospitale) and Copenhagen (Bispebjerg Hospital). Her main research interest involves the pathogenesis and management of patients with COPD and asthma, including clinical and mechanistic studies.
Edmund Lau is an academic respiratory physician working at Royal Prince Alfred Hospital, Sydney and Associate Professor of Medicine at the University of Sydney. He is the lead Respiratory Physician of the Pulmonary Hypertension Service at Royal Prince Alfred Hospital. He is the Medical Director of the Australian and New Zealand Pulmonary Hypertension Registry. He has authored more than 100 peer-reviewed publications, mostly on the topic of pulmonary hypertension. He is Associate Editor of Respirology and he participated in ERS Task Force on pulmonary circulation.
Dr. Kristen Lee is a consultant interventional radiologist, practicing at the Singapore General Hospital (SGH). Dr. Lee completed her diagnostic radiology training at the Mallinckrodt Institute of Radiology, Washington University at St. Louis, and interventional radiology fellowship at University of California, San Francisco, in USA. She is one of the IR leads in establishing the PERT service at SGH and has special clinical interest in percutaneous pulmonary interventions.
Professor YC Gary Lee is a clinician researcher and world leader in Pleural Medicine. He is a Professor of Respiratory Medicine at the University of Western Australia and leads the pleural service at Sir Charles Gairdner Hospital in Perth which is one of the busiest in Australasia. He established the Southern Hemisphere’s first translational pleural program in UWA and founded the Australasian Malignant PLeural Effusion network. His work has translated into clinical practice and informed clinical guidelines on many occasions and improved pleural care worldwide. He has published 300+ papers on pleural diseases (H-index 65), delivered 300+ invited lectures in 32 countries and won successive NHMRC Fellowships. He has trained many next generation pleural specialists from 10+ countries.
Dr. Kyung Soo Lee is a professor in the thoracic imaging section at the Department of Radiology in the Sungkyunkwan University School of Medicine and in the Samsung ChangWon Hospital. His research interests focus on the diagnosis and management of lung cancer, interstitial lung disease, and pulmonary tuberculosis and nontuberculous mycobacterial pulmonary disease (NTM-PD). He is member of the Fleischner Society and an honorary member of European Society of Thoracic Imaging.
Dr. Kang-Yun Lee is Professor of Internal medicine and Vice President of Taipei Medical University (TMU). He also heads the Asthma Assembly of Asian Pacific Society of Respirology. Dr. Lee qualified his first degree of Medicine at TMU and received a PhD in clinical pharmacology at imperial College London in 2006.
Dr. Lee had been working on pathogenesis of asthma, COPD, and lung cancer. In addition to clinically orientated research, he has been working on molecular control of inflammation and immunity in lung diseases. He is interested in microenvironment and immune therapy for lung cancer. His lab identified a novel myeloid-derived suppressor cell (MDSC) in lung cancer, which has been implicated in tumor aggressiveness and drug resistance. Dr. Lee also participates in a great number of clinical trials, in variable lung diseases, including airways diseases, lung cancer and pneumonia.
Lee Pyng is Professor, Yong Loo Lin School of Medicine, National University of Singapore.
She is also Director of Interventional Pulmonology, Division of Respiratory and Critical Care Medicine, National University Hospital. Associate Professor Lee has an active interest in lung cancer, pleural disease, obstructive airway disease, bronchoscopy and pleuroscopy. She was the past President of Singapore Thoracic Society, and serves on international scientific committees in Lung Cancer, Bronchology and Interventional Pulmonology as well as American College of Chest Physician Steering Committees. She represents Singapore as Global Governor for American College of Chest Physicians and is invited locally and overseas to speak and instruct in pleuroscopy, bronchoscopy, bronchial thermoplasty and lung cancer. Associate Professor Lee is the author of publications in peer-reviewed journals, has written a manual and a book on pleuroscopy that worn the British Medical Association Best Book Award in internal medicine in 2011. She received the Young Investigator’s award 2000 for work in asthma, Best Poster Award for research in talc and cancer cells at CHEST 2006, Best Original Investigation and Presentation at Chest World Congress 2014, and the Geoffrey McLennan Award for advancing the field of Interventional Pulmonology at CHEST 2014, Austin, Texas. In 2018, she was conferred AC Shah Oration Award for Woman Researcher in Interventional Pulmonology by Indian Association for Bronchology. She has completed her PhD on New Applications of Bronchoscopic Techniques conferred by Vrije University, Amsterdam in 2014, first in Respiratory medicine
She also received Best Teacher Award in 2012 for undergraduate education, National University Hospital teaching excellence award for post-graduate education in 2014, and the prestigious Outstanding Tutor Award by National University of Singapore Medical Society. She is recently conferred the prestigious Pasquale Ciaglia award by CHEST 2019 for Interventional medicine.
Dr Chi Chiu Leung
Honorary Consultant of the Hong Kong Tuberculosis
Chest and Heart Diseases Association
Dr Chi Chiu Leung graduated from The University of Hong Kong in 1983 and underwent postgraduate training in respiratory medicine and public health, and research fellowship in Stanford University Medical Centre. He previously served as Consultant Chest Physician and headed the Public Service Branch of the Centre for Health Protection, Department of Health, Hong Kong, China. He was the principal investigator of the Hong Kong study site of the Tuberculosis Trial Consortium from 2009 to 2018 and chaired the Pneumoconiosis Medical Board from 1996 to 2018. He previously served in the editorial board of the American Journal of Respiratory and Critical Care Medicine and chief editor of the International Journal of Tuberculosis and Lung Disease. He is currently a deputy editor of Respirology and honorary consultant of the Hong Kong Tuberculosis, Chest and Heart Diseases Association. He has published over 200 articles in peer-review journals with over 10000 citations.
Research leadership: Prof Le Souëf is an academic scientist and respiratory and global health paediatrician. He has published >310 peer-reviewed publications, given >300 invited presentations at international scientific meetings, universities and institutes in 46 different countries, and had research collaborations in North and South America, Africa, Asia and Europe. He was Head, UWA School of Paediatrics for 20 years.
Respiratory research: He was worked in many areas of children’s respiratory research, particularly on early factors influencing children’s respiratory health. He currently heads the Mechanisms of Acute Viral Respiratory Infection in Children (MAVRIC) research team.
Future child health – the effect of environmental decline and increasing world population. He heads a new research group studying the effect of environmental deterioration and overpopulation on future children’s health.
Professor Jing Li Professor, Respiratory Medicine
Director, Department of Allergy and Clinical Immunology
Guangzhou Institute of Respiratory Health
State Key Laboratory of Respiratory Disease
The First Affiliated Hospital
Guangzhou Medical University
Professor of Medicine, Doctoral supervisor, The First Affiliated Hospital of Guangzhou Medical University
Director, Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Diseases
Member, Asthma Committee, World Society of Allergy (WAO)
Member of the Standing Committee of Allergy Branch of Chinese Medical Doctor Association
Chairman of the Allergy Branch of Guangdong Medical Association, deputy leader of the asthma Group of the Respiratory branch
Guangzhou high-level talent and outstanding expert, Guangdong medical leading talent, Second echelon of “Outstanding Figure Project of South China”
Research grants funded by Natural Science Foundation of China and Ministry of Science and Technology of China for mechanisms of allergen specific immunotherapy, environmental influence of immune regulation in childhood asthma, precision diagnosis and treatment of asthma
Authorship a total of 64 peer-reviewed, 17 review scientific journal articles, and book chapters
Professor Dr. Liam Chong Kin, is an Emeritus Professor of the University of Malaya, Kuala Lumpur and Senior Consultant Respiratory Physician practicing at the Universiti Malaya Medical Centre and UM Specialist Centre.
He is a fellow of the American College of Chest Physicians, Royal College of Physicians (London) and the Asian Pacific Society of Respirology. He is an active member of the International Association for the Study of Lung Cancer, the European Respiratory Society and the Malaysian Thoracic Society. He used to head the Lung Cancer Assembly of APSR.
His clinical and research interests include molecular targeted therapies and immunotherapy for lung cancer. He has published extensively and presented at many regional and international scientific meetings.
Senior consultant at the Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore. Adjunct Associate Professor, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore and Yong Loo Ling School of Medicine, National University of Singapore. A/Prof. Lim is also a clinical consultant at the Singapore-MIT Alliance for Research and Technology (SMART).
A/Prof. Lim completed his specialist training in respiratory and internal medicine in UK. He has a doctorate in medicine (M.D) awarded at a higher degree from the University of Glasgow. A/Prof. Lim is an expert in airway diseases, pulmonary infection and aspergillus lung diseases. He established and led the Bronchiectasis care programme since 2016 and non-tuberculous mycobacteria (NTM) service since 2019.
A/Prof. Lim is a PI and CO-I of multiple research grants such the NRF grant. His research focus is on clinical outcome prediction of airway diseases such as bronchiectasis, contemporary approach to diagnosis and treatment of bronchiectasis and NTM infection. A/Prof. Lim is also actively involved in new drug discovery and innovation on medical device to improve lung health.
A/Prof. Lim is the principal lead in respiratory medicine of the Lee Kong Chian School of Medicine. He has a strong passion on teaching. He was also served at the ministry of health on various committees.
Dr. Rebecca Chou-Jui Lin is a pulmonologist at Taoyuan General Hospital, Ministry of Health and Welfare, Taiwan. She specializes in tuberculosis (TB) treatment, serves as regional TB consultant, and is one of the board of directors of Taiwan Society of Tuberculosis and Lung Diseases. She has been leading one of the five Taiwan Multidrug-resistant Tuberculosis Consortium (TMTC) teams since 2007, and actively involved in introducing shorter regimens and active drug safety monitoring system for multidrug-resistant TB in Taiwan. She also participated in providing technical assistance regarding uptake of shorter regimen of drug-resistant TB in the Philippines and facilitated in several online international training courses of clinical management of drug-resistant TB over the past few years.
Dr Shaun Loh is a consultant at the Department of Otorhinolaryngology, Head and Neck Surgery (ENT) at Singapore General Hospital. He is also Clinical Assistant Professor at Yong Loo Lin Medical School and Duke-NUS Medical School.
His special interest is in the treatment of Obstructive Sleep Apnea and aims to offer holistic and cutting edge treatment to OSA patients. He has played an integral part in introducing hypoglossal nerve stimulation therapy in Singapore.
Andreas L. Lopata is Professor of Medical Sciences in the College of public health, medical and veterinary sciences at James Cook University, Townsville, Australia. Since 2011 he is head of the Molecular Allergy Research Laboratory in the Australian Institute of Tropical Health and Medicine and since 2021 Prof Research Fellow in the Tropical Futures Institute at James Cook University-Singapore.
He is considered one of the world leaders on food allergies to seafood and has contributed to the development of national and international guidelines. His predominant focus has been on developing and employing advanced molecular technologies to investigate allergenic proteins, understand the interactions of allergens with the immune system and to develop novel interventions and therapeutics for food allergy.
Prof Lopata is principal investigator in the Centre for Food Allergy Research, a NHMRC Centre for Research Excellence since 2013, and the National Allergy Centre of Excellence, aiming at the facilitation and acceleration of allergy research to reduce the incidence of food allergies and translation into clinical practice.
He promotes translational science with over 250 publication and editorial board support on leading journals, including section editor Asia-Pacific of the WAO World Allergy Organisation Journal.
Dr Low is currently a Senior Consultant in the Department of Respiratory & Critical Care Medicine at the Singapore General Hospital.
Her special interest is in Interstitial Lung Disease for which she spent some time at the Royal Brompton Hospital, United Kingdom, learning from world renowned physicians in this area.
She is a Clinical Senior Lecturer at the NUS Yong Loo Lin School of Medicine; Clinical Associate Professor, Duke-NUS Medical School; Physician Faculty, SingHealth Respiratory Medicine Senior Residency Programme; Clinical Teacher at the Lee Kong Chian School of Medicine, Singapore.
Chong Ying is a Senior Dietitian with Tan Tock Seng Hospital. She graduated from Curtin University with a Masters of Dietetics. She has clinical experience in working with a wide range of patients to improve their nutritional knowledge and intake, and to manage their acute and/or chronic diseases. Her keen areas of interest are in respiratory disease and intermediate rehabilitation, where she strives to collaborate with stakeholders, deliver evidence-based and patient-centred nutrition care and improve patients’ quality of life.
Dr. Lui is the consultant physician of Queen Mary Hospital and the honorary clinical associate professor of The University of Hong Kong. She is the Director of Cluster Sleep Service, Hong Kong West Cluster. She received her undergraduate training at the Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKU). After a series of research endeavour on sleep disordered breathing, she also attained Doctor of Medicine (MD) HKU, with research focus on biomarkers in cardio-metabolic complications of obstructive sleep apnoea. She is currently the Honorary Secretary of the Hong Kong Thoracic Society. She has numerous publications in peer-reviewed journals and textbooks, and is currently the Deputy Editor of Respirology, the official journal of the Asia Pacific Society of Respirology.
John J. Marini, M.D. Professor of Medicine, University of Minnesota (USA). He was educated and trained at Johns Hopkins School of Medicine and at the University of Washington. Presently Dr. Marini is a member of numerous editorial boards, an author and editor of 11 medical textbooks, and contributor to more than 350 scientific and educational articles. His investigative work has always concentrated in understanding the cardiopulmonary physiology and management of acute respiratory failure, with an emphasis on defining the mechanisms underlying the patient-ventilator interactions which occur during critical illness. In the majority of that research, he has been positioned at the interface between basic physiology and clinical medicine so as to develop mechanistic insights that advance clinical practice. Refining our understanding of ventilator-induced lung injury is a theme he currently pursues with collaborators at the bench, laboratory, and clinical levels.
Fernando J Martinez is Chief of the Division of Pulmonary and Critical Care Medicine at Weill Cornell Medical College, New York. Prior to this appointment, he was Professor of Internal Medicine and Associate Chief for Clinical Research in the Division of Pulmonary and Critical Care Medicine at the University of Michigan Health System, Ann Arbor, Michigan, as well as Medical Director of its Pulmonary Diagnostic Services and Co-Medical Director of the Lung Transplantation Program. After graduating from the University of Florida School of Medicine, Gainesville, Florida, he completed a residency in internal medicine at Beth Israel Hospital, Boston, Massachusetts, and a fellowship in pulmonary medicine at the Boston University Pulmonary Center. He received a Masters in Biostatistics and Clinical Study Design from the University of Michigan School of Public Health.
Professor Martinez’s main research interests include the biological underpinnings and therapeutic approaches to interstitial lung diseases (ILD) and chronic obstructive pulmonary disease (COPD). He is a member of numerous societies, including the American Thoracic Society (ATS), the European Respiratory Society (ERS), the American College of Chest Physicians, and in the past the Fleischner Society. Previously, he was a member of the ATS Committees which generated guidelines for the management of COPD, respiratory infections, idiopathic pulmonary fibrosis, and cardiopulmonary exercise testing. He is the former Chair of the Clinical Problems Assembly of ATS. Professor Martinez is a member of the GOLD Science Committee and sits on a number of editorial boards, including for Journal of COPD and American Journal of Respiratory and Critical Care Medicine. He serves as the Editor-in-Chief for the latter.
Hiromi Matsubara, MD, PhD, is currently the Deputy Director of National Hospital Organization Okayama Medical Center, Okayama, Japan. After finishing his fellowship at National Cardiovascular Center, Osaka, Japan in 1993. He became an Assistant Professor of Department of Physiology II at Okayama University Graduate School of Medicine and Dentistry. He became an Assistant Professor of Department of Cardiovascular Medicine in 1997 and the Associate Professor in 2000. He then became the Clinical Professor of Department of Cardiovascular Medicine and the Director of Department of Cardiology at Okayama Medical Center.
His investigative interests have focused on clinical and physiologic aspects of pulmonary hypertension. He started balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension in 2004 and has experienced about 3000 procedures of BPA in more than 500 patients during 19 years. He has made Department of Cardiology at Okayama Medical Center as the largest BPA center in Japan.
Dr. Mehra is a physician scientist, Professor of Medicine of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Director of Sleep Disorders Research focused on investigation of sleep disorders and health outcomes with a focus on cardiopulmonary disease. She has almost 20 years of experience in the conduct of clinical and translational science and leading the Sleep Coordinating Center for multicenter studies. She is Chair of the American Heart Association Statement on Sleep Apnea and Cardiac Arrhythmia, Co-Chair of the NHLBI Autonomic Nervous System Cardiopulmonary Interactions workshop, immediate past Chair of the American Thoracic Society Sleep Respiratory Neurobiology Assembly, Chair of the American Academy of Sleep Medicine Inpatient Diagnostic Sleep Testing Task Force, and Associate Editor of the American Journal of Respiratory and Critical Care Medicine. Dr. Mehra has over 200 publications, delivered >300 lectures and mentored more than 40 trainees
Professor Mohammad Ashkan Moslehi is a board-certified pediatric interventional pulmonologist. He leads the Pediatric Interventional Pulmonology Division at Shiraz University of Medicine Sciences and holds several prestigious positions in international associations. He is an expert in various bronchoscopy techniques and Pleuroscopy among the neonates, infants and children. He is the chairman of the World Association for Bronchial and Interventional Pulmonology (WABIP)-Pediatrics, the Board of Directors of WABIP, the co-founder and vice president of the Asian Association of Pediatric Interventional Pulmonology (APIPA). He has founded the International Association of Pediatric Airway Team (INPAT). He also serves as the chairman of the WABIP Award Committee member, reviewing nominations and award applications for the Killian Centennial Medal, WABIP-Dumon Award, and Heinrich Becker Award for Clinical Research and Innovation.
Dr Naveed Mustfa is a Consultant in Respiratory Medicine at the University Hospital of North Midlands. He is lead for the Midlands Regional Complex Home Ventilation and Weaning Unit. He has been a director the North Midlands Motor Neurone Disease (MND) Research and Care Centre since 2008 that provides care across Staddordshire, Cheshire, Shropshire and part of North Wales.
He performed his research on respiratory muscle weakness and respiratory compliations in MND at King’s College London and completed a PhD and with the team published articles on the effects of non-invasive ventialtion on people with MND and their carers, the effects of cough assist and diaphragm emg recoring with surface electrodes.
He is also an honorary lecturer at Keele University and Medical School.
Dr Mustfa is also the clinical lead for the Bedside Clinical Guideline Partnership (BCGP) producing guidelines for the region and is worling with the Computer Sciences Departments at Keele University and University of Colorado School of Medicine to produce an evdence based guidelines application.
Prof. Jun-Pyo MYONG has carried out the education, research, medical treatment on Occupational and Environmental Medicine in Seoul St. Mary’s Hospital, College of Medicine, the Catholic University of Korea. He also has his sub-special as occupational and environmental respiratory diseases such as pneumoconiosis (Silicosis, Coal Workers’ pneumoconiosis, and asbestosis), Humidifier Disinfectant induced Lung disorder, etc. He has a broad backgrounds for Occupational and Environmental Respiratory diseases, with clinical aspects for Epidemiology, Preventive Medicine, Field Survey, and Big data analysis. As a deputy head of WHO CC for Occupational Health (KOR-09; CIMC), he is participating in many projects with researchers in many countries for occupational and environmental lung disease issues.
Professor Yasutaka Nakano is a physician-scientist. He graduated in medicine from Kyoto University, Japan, and received his medical license. After completing his residency and obtaining board certification in pulmonary medicine, he began his research career. His research focused on the structure-function relationship of lung diseases, and he mainly used computed tomography (CT) data and quantitatively evaluated various parameters of lung structures. He is one of the first to develop software for quantitative evaluation of lung structures. Using the original software, he studied the relationship between lung structural changes and functional changes, including pulmonary function tests, physical constitution, symptoms, prognosis, and so on. Chronic obstructive pulmonary disease (COPD) is his main research target disease, and he proposed the phenotyping of COPD, which has been widely accepted worldwide. He is now a professor of medicine at Shiga University of Medical Science, Japan, and he continues to conduct research vigorously.
Professor Calvin S.H. Ng Professor, Thoracic Surgery
Department of Surgery
The Chinese University of Hong Kong
Dr Ng graduated from Imperial College, London in 1999 with honours, and received his training in cardiothoracic surgery in Hong Kong and UK. He is a pioneer in single port VATS, hybrid operating room image guided surgery, navigation and robotic bronchoscopy, and endobronchial ablation therapies. He is co-PI in NAVABLATE, TARGET, INCITE-ES and POWER studies among others, investigating these technologies. His academic contributions include more than 270 publications in indexed international journals, as well as books and book chapters.
Dr Ng Ziqin studied medicine at Yong Loo Lin School of Medicine, National University of Singapore, and graduated in 2015. She obtained the Membership of the Royal Colleges of Physicians (UK) and Master of Medicine (Singapore) in 2017. Dr Ng is dually accredited as a specialist in both Respiratory Medicine and Intensive Care Medicine. Her passion lies in managing patients with interstitial lung disease (ILD) and believes in providing personalised expert care for her patients. She is currently practising at Tan Tock Seng Hospital in Singapore, where she also runs the ILD service. Dr Ng has publications in both local and international journals. She is also actively involved in educating medical students and is a clinical tutor and teacher in both Yong Loo Lin School of Medicine and Lee Kong Chian School of Medicine respectively.
Dr Joanne Ngeow, BMedSci, MBBS, FRCP, MPH is Senior Consultant, Division of Medical Oncology at the National Cancer Centre Singapore and Associate Professor (Genomic Medicine) at the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore. Dr Ngeow currently heads the Cancer Genetics Service at the National Cancer Centre Singapore with an academic clinical interest in hereditary cancer syndromes and translational clinical cancer genetics. Dr Ngeow is funded by the National Medical Research Council Clinician Scientist Award and Ministry of Health to explore how gene-environmental interactions predisposes to cancer initiation and progression and the implementation of genomics into routine clinical care. Dr Ngeow is one of the Principal Investigators of the Health for Life in Singapore Study (HELIOS), a state-of-the-art multi-ethnic population cohort study.
Yeon-Mok Oh is a professor of medicine at the Department of Pulmonary & Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. In addition, he is a president of Obstructive Lung Disease Research Foundation in Korea.
Prof. Oh completed his medical degree at the Seoul National University College of Medicine in 1990, and subsequently underwent general internal medicine and pulmonary medicine training at the Seoul National University Hospital. From 2000 to 2002, he had a postdoctoral fellowship at Cardiovascular Research Institute, Univ. California San Francisco, San Francisco, CA, USA. In addition, he was a visiting professor at Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, MA, USA. Prof. Oh earned his MS degree from the Seoul National University in 1994, and his PhD in 2006.
Prof. Oh is an authority on the respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma and bronchiectasis. He is the author of more than 466 publications and the textbook which provides readers with an overview of COPD, the current understanding of its pathobiology, and a contemporary approach to diagnosis and treatment. Moreover, he has actively led the clinical trials for COPD, asthma and bronchiectasis based on clinical big data as the principal investigator.
Rick is a bioinformatician who combines computer science, statistics, population genetics and genomics to develop and apply novel algorithms and software in the research and analysis for pathogenesis and molecular epidemiology of infectious diseases, including monitoring of antimicrobial resistance for public health surveillance. He is currently an Assistant Professor with the Saw Swee Hock School of Public Health at the National University of Singapore.
Professor Hye Yun Park is a member of KATRD (Korean Academy of Tuberculosis and Respiratory Disease) and Korean Association of Internal Medicine. She has been under postdoctoral fellowship in UBC James Hogg Research Center the Institute for Heart and Lung Health in Canada from July 2011 to Sep 2013. She was awarded for Young Scheweitzer Award in 2009, for Best fellow presenter in internal medicine of Samsung medical center in 2010, and for LG future medical researcher in 2013. She has published over 100 SCI(E) articles (publications as first/corresponding author) mostly about COPD and asthma. She serves as the Associate Editor of European Respiratory Journal.
Full Name: Sunghoon Park
Job title: Professor
Institution: Hallym University Sacred Heart Hospital
1992-1998 College of Medicine, Hallym University, Awarded M.D. Degree in Medicine
2000-2002 Graduate School, Hallym University, Awarded M. Msc Degree in
2007-2011 Graduate School, Hallym University, Awarded M. Doc Degree in Medicine
1998-1999: Internship, Hallym University Kangdong Sacred Heart Hospital, Republic of Korea
1999-2003: Residency, Hallym University Kangdong Sacred Heart Hospital, Republic of Korea
2006-2008: Fellowship, Pulmonary and Critical Care Medicine, Samsung Medical Center, Republic of Korea
2008-2013: Assistant Professor, Pulmonary and Critical Care Medicine, Hallym University Sacred Heart Hospital, Republic of Korea
2014 (1 year); Observational fellowship, ECMO program in NYPH/Columbia University Medical Center, New York, U.S.A.
2014-2020: Associated Professor, Pulmonary and Critical Care Medicine, Hallym University Sacred Heart Hospital, Republic of Korea
2021-present: Professor, Pulmonary and Critical Care Medicine, Hallym University Sacred Heart Hospital, Republic of Korea
Member of the Korean Association of Tuberculosis and Respiratory Disease (KATRD)
Board member of committee, The Korean Society of Critical Care Medicine (KSCCM)
Ian D Pavord, MA DM FRCP FERS FMedSci is Professor of Respiratory Medicine at the University of Oxford and Honorary Consultant Physician at the Oxford University Hospitals. He is a member of congregation at the University of Oxford and a Professorial Fellow of St Edmund Hall. He was a Consultant Physician from 1995 and Honorary Professor of Medicine from 2005 to 2013 at the Institute for Lung Health, Glenfield Hospital, University Hospitals of Leicester NHS Trust. He was elected an NIHR Senior Investigator in 2011&14, an inaugural Fellow of the European Respiratory Society in 2014 and a Fellow of the Academy of Medical Science in 2015.
He has a research interest in the clinical aspects of inflammatory airway diseases and has pioneered the use of non-invasive measures of airway inflammation in the assessment of these conditions. He has identified a number of clinically important phenotypes of inflammatory airway disease, has discovered clinically important biomarkers, and has played a lead role in the clinical development of three of the most promising new treatments for severe airway disease.
Professor Pavord was co-editor of Thorax from 2010-2015, Chief Medical Officer of Asthma UK from 2008-14, Associate Editor of the American Journal of Respiratory and Critical Care Medicine from 2005-10 and has been Associate Editor of the European Respiratory Journal since 2016. He is the author of over 550 publications and has an H-index of 123 making him the 2nd highest cited researcher in asthma worldwide. He received the 2016 European Respiratory Society (ERS) Gold Medal for his research and gave the Cournand Lecture at the 2004 ERS meeting. He chaired the 2017 Lancet Commission on asthma.
Before joining NTU as an Associate Professor of Infectious Diseases, Kevin Pethe gained expertise in R&D in the private sector as research investigator at the Novartis Institute for Tropical Disease (Singapore), and at Institut Pasteur Korea (2011-2014) where he held various positions, including head of the department, and acting CEO. He is an expert on infectious diseases, in particular on therapeutics development for difficult to treat bacterial infection such as tuberculosis or non-tuberculous mycobacteria (NTM)
Dr Phan Thu Phuong
Director of Respiratory Center -Bach Mai Hospital
Lecturer of Internal Medicine Deptment – Hanoi Medical University
Vice President of Hanoi Respiratory Society (VNRS)
A/Prof Phan Thu Phuong has the expertise, leadership, training, and motivation necessary to successfully carry out the proposed research project. She has more than 15 years’ experience in pulmonary and critical care, with specific training and expertise in respiratory medicine
She has conducted many studies related to pulmonary disease as a PI or Co-Investigator. She have published 20 chapters and books as an author and co-author printed by Medical Publishing house of Vietnam.
Professor Price is the Founder and Head of the Observational and Pragmatic Research Institute (OPRI) in Singapore, conducting real-life, pragmatic, and observational research, delivering clinical trials and database research across various regions, including the United States, Europe, and the Asia-Pacific area. Additionally, Professor Price is the Head of Optimum Patient Care (OPC) Global in Australia and the UK, a social enterprise focused on disease registries and quality improvement in healthcare. He established the Optimum Patient Care Research Database (OPCRD), which holds data from over 1100 general practices and 19.5 million patients in the UK. Professor Price leads the International Severe Asthma Registry (ISAR) and the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care (CONQUEST) registries. With over 888 peer-reviewed publications, an H-index of 103, Professor Price specializes in clinical trial design, exploring ways to improve adherence to treatment plans, and understanding patient attitudes towards respiratory diseases.
Dr. Puah Ser Hon is a Senior Consultant Respiratory Physician and Intensivist working in the Respiratory and Critical Care Medicine Department in Tan Tock Seng Hospital where he currently leads as the Head of Department.
He started his career as a House Officer in Queen Elizabeth Hospital in Kota Kinabalu, the main city of the state of Sabah in Malaysia in 2004. He subsequently worked in Tawau General Hospital in the town of Tawau, which is also in Sabah, and eventually went back to Queen Elizabeth Hospital under the Ministry of Health, Malaysia. He joined Tan Tock Seng Hospital in 2011 and was trained both in Respiratory and Intensive Care Medicine. He is also He is also an Adjunct Senior Lecturer in Lee Kong Chian School of Medicine and a Clinical Lecturer for Yong Loo Lin School of Medicine from the National University of Singapore.
He is a keen educator and enjoys teaching. He recently acquired the International Masters of Science in Health Professionals Education from Maastricht University. He was previously the Programme Director for the National Health Group Respiratory Medicine Residency Programme and Clinical Director for the Respiratory Therapist services in Tan Tock Seng Hospital.
He regularly conducts lectures and bedside tutorials for Residents and non-Resident Medical Officers, at the Yong Loo Lin School of Medicine and Lee Kong Chian School of Medicine.
His field of interest includes obstructive airway diseases, bronchiectasis and acute respiratory distress syndrome.
Dr. Hanyu Qin was trained as an intensivist in Peking Union Medical College Hospital, Beijing. Her previous research focused on clinical application of metagenomics in causative microbiome investigation among ventilated patients due to severe pneumonia. Meanwhile, she was interested in sepsis susceptibility and endotypes. She joined Oxford for further training in Statistics on big data, eg. Transcriptomics, Proteomics. Her current project involves primary clustering of host response to severe pneumonia or lung infiltration secondary to all cause sepsis using Olink proteomic assay, effects of immunomodulator intervention at biology level within trials, potential of single cell assay in identifying deleterious neutrophil roles from bronchoalveolar lavage fluid.
Prof. Rhee is a member of editorial board of American Journal of Respiratory and Critical Care Medicine, Journal of COPD, BMC Pulmonary Medicine, Frontiers in Medicine, Journal of Thoracic Disease, Journal of Korean Medical Science, and Life. He is also a Deputy Editor of Tuberculosis and Respiratory Diseases.
Prof. Rhee is a member of long-range planning committee of ERS Assembly 5. He is also a Chairperson of APSR Research Committee, Head of APSR COPD assembly, and a member of Planning and Action Committee on APSR Development. He is a member of steering committee of International Severe Asthma Registry. He is also a member of many committees of Korean Academy of Tuberculosis and Respiratory Disease.
Prof. Rhee has published 250 SCI(E) articles (98 publications as first/corresponding author). The focus of his research is COPD and asthma.
Dr. Rivera joined the University of Rochester in 2022 as the C. Jane Davis & C. Robert Davis Distinguished Professor in Pulmonary Medicine, Chief of the Division of Pulmonary and Critical Care Medicine, and Associate Director of Diversity, Equity, and Inclusion at Wilmot Cancer Center in the University of Rochester Medical Center, Rochester, New York.
Her expertise includes screening, diagnosing, staging lung cancer, and managing treatment complications.
Before moving to Rochester, NY, Dr. Rivera was a Tenured Professor of Medicine in the Pulmonary and Critical Care Medicine Division at Chapel Hill University of North Carolina (UNC). She co-founded the first Multidisciplinary Thoracic Oncology Program in 1995, paving the way for pulmonologists to contribute to the care of lung cancer patients. In 2015 she developed the Multidisciplinary Lung Cancer Screening Program at UNC.
Dr. Rivera Co-developed and Co-directs the North Carolina Lung Screening Registry, a research registry that partners with community and academic imaging sites across the state to generate real-world evidence on the delivery, quality, and outcomes of lung cancer screening. She is an NIH/NCI-funded researcher and collaborates with colleagues at URMC to examine interventions that can improve lung cancer screening rates at URMC and the catchment area.
Throughout her career, Dr. Rivera has held numerous leadership positions in professional societies including Chest, the National Lung Cancer round Table, and the American Thoracic Society.
Dr. Rivera is passionate about teaching, mentoring, and developing the next generation of leaders and increasing the representation of women and underrepresented groups in pulmonary and critical care medicine.
Dr RUAN Wen is a senior consultant with the Department of Cardiology at National Heart Centre Singapore. Her clinical speciality interest is in echocardiography and pulmonary hypertension. She completed her postgraduate MRCP (UK) in 2012. On successfully completed her Advanced Specialty Training in Cardiology in 2015. She received scholarship from Singapore Health Manpower Development Plan and went on further training in pulmonary hypertension in Royal Papworth Hospital in Cambridge, UK in 2018. Since returning to NHCS, she runs a pulmonary hypertension clinic, and is an active member of multidisciplinary pulmonary hypertension team.
Professor Sejal Saglani Faculty of Medicine, National Heart & Lung Institute
Professor of Paediatric Respiratory Medicine
Professor Sejal Saglani leads the Paediatric Severe Asthma Group within the section of Inflammation, Repair and Development at Imperial College London. She is consultant in Paediatric Respiratory Medicine at the Royal Brompton Hospital and part of the Paediatric Difficult Asthma Team.
Areas of expertise and research interests
Professor Saglani’s clinical expertise and research interests include:
management of pre-school children with recurrent wheezing
management of school age children with difficult asthma
factors predicting progression of pre-school wheeze to school-age asthma
the identification of novel therapies for pre-school wheeze and childhood severe asthma
mechanisms mediating severe pre-school wheezing and childhood asthma
Professor Saglani has established a translational research programme. It involves an integrated approach using a neonatal murine model, airway samples from children and direct application and clinical translation of her findings in interventional clinical trials.
President, Indian Chest Society, 2023-2024
Member, Board of Directors, Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Member, Scientific Committee, Global Initiative for Asthma (GINA)
Chair, Chronic Respiratory Diseases Section, Global Burden of Disease, India (2015 onwards)
Member, Steering Committee on Air Pollution and Health, Ministry of Health and Family Welfare, GoI
More than 250 published papers in peer reviewed international journals
Ranked No. 1 Respiratory Scientist in India (Stanford University Ranking 2023, previous year) and No. 52 in the world out of 60,472 global respiratory scientists
Dr Sewa Duu Wen obtained his medical degree from the National University of Singapore in 2003. He completed his specialty training in Respiratory and Critical Care Medicine, as well as Intensive Care Medicine in 2012 and 2014 respectively.
Dr Sewa’s areas of interest include advanced respiratory failure, pulmonary hypertension and lung transplantation. In 2013 and 2015, he was twice awarded the Health Manpower Development Programme (HMDP) Award for training in intensive care medicine and lung transplantation at University Health Network, Toronto, Canada, and then at Papworth Hospital, Cambridge, UK for training in chronic thromboembolic pulmonary hypertension. He is part of the multi-disciplinary team member of the pulmonary hypertension service in National Centre and is the medical director for lung transplantation programme in Singapore. He is currently serving as the Head of Department of Respiratory and Critical Care Medicine in Singapore General Hospital.
Dr Kiran Sharma, is the Deputy Head, Department of Intensive Care Medicine and Consultant, Department of Respiratory Medicine at Sengkang General Hospital in Singapore. She is also the Clinical Lead for the Pleural Medicine. She did a short pleural fellowship at the Sir Charles Gairdner Hospital in Perth, Australia. Her special interest includes Pleural Medicine, Rapid Response Team, Code Blue Resuscitation and Pulmonary Embolism. She is actively involved in teaching of undergraduates, postgraduates and advanced critical care nursing.
Michael J. Simoff has practiced Interventional Pulmonology for 29 years and has been involved in technology development including: EBUS-TBNA, ENB, confocal microendoscopy, OCT, autofluorescence bronchoscopy, and APC as examples. He is a Professor of Medicine, FTA at Wayne State School of Medicine. He has published more than 180 peer-reviewed works, given more than 230 international and national talks, and has been funded more than $18million for research. He has served on international and national committees throughout his career in interventional pulmonology and lung cancer. He is currently the Director of Interventional Pulmonology and Lung Cancer Screening at Henry Ford Hospital. He also works as an Associate Medical Officer for Intuitive, working on new technology development and design of research surrounding this work.
When not at work, he looks forward to spending time with his wife of 34 years. He also enjoys traveling, photography, hiking, golfing, cycling, woodworking, gardening, and he is a beekeeper.
Asst Prof. Sinha is a physician-scientist trained in the U.K. and practicing in the U.S. His research interests include lung biology and immune responses, respiratory physiology, and data science. As a clinician, he specialises in Intensive Care and Emergency Medicine. His group are studying molecular biology in critical care syndromes such as sepsis and ARDS. He uses multidimensional biological and clinical data to find biologically homogeneous subgroups in ARDS and sepsis with a view to developing precision-based care in the ICU. As a data scientist he uses cutting-edge tools to understand biological data at a population-wide level and to seek subgroups in clinical trials that may be treatment responsive or how we can better design trials that can evaluate treatment efficacy at an individual level. Through these novel tools he hopes to improve patient outcomes by matching the right therapies to the right patient at the right time.
Dr. Yuanlin Song is the Director of Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University; He is also the Standing committee member, Chinese Thoracic Society; Standing committee member, APSR; President, Shanghai respiratory society; Past Assembly Head, Respiratory Infectious Disease, Asia Pacific Society of Respirology and Associate Editor, Respirology.
He has authorized more than 200 publications in JAMA-internal Medicine, Lancet, JCI, Critical Care Med, Am J Respir Crit Care Med, Stem Cell, etc, with H-index 59. He also got 20 approved patents and coauthored 12 book chapters.
Asso. Prof Sng Li-Hwei Is a Senior Consultant at the Central Tuberculosis Laboratory, Department of Medicine, Singapore General Hospital. She served the Head of CTBL and has been in various biosafety and TB guidelines committees of the Ministry of Health, Singapore, and the Singapore Tuberculosis Elimination Program. Her interests are in laboratory diagnosis of mycobacteria, in particular, the identification and epidemiology of multidrug resistant organisms.
Dr Arietta Spinou is a cardiorespiratory physiotherapy lecturer and researcher at King’s College London, United Kingdom. Dr Spinou holds a PhD in Respiratory Medicine, King’s College London, and an MSc in Cardiorespiratory Physiotherapy, UCL. She also has over 13 years of clinical experience in Greece, Finland and the UK.
Dr Spinou is a member of the British Thoracic Society (BTS) Pulmonary Infection Specialist Advisory Group and was a chair of the European Respiratory Society (ERS) airway clearance in bronchiectasis statement panel (2023). Her research interests include bronchiectasis, quality of life, cough physiology and outcomes, and airway clearance techniques.
Alastair is Chair of Pharmacology and Therapeutics at University of Melbourne and Director of the ARC Industrial Transformation Centre for Personalised Therapeutic Technologies. He focusses on drug targeting in remodelling and inflammation. He is CSO and Director of TianLi Biotech and President of the Asia Pacific Federation of Pharmacologists.
Sun Tao is the Advanced Practice Nurse in Home Ventilation and Respiratory Support Service (HVRSS) of Tan Tock Seng Hospital. Trained in China, she started as an enrolled nurse in a multi-disciplinary ICU in Singapore. 10years of ICU experience enabled her to became the first nurse in HVRSS in 2012. Over the years, she led HVRSS nurses to venture and expand in the scope of service, such as tracheostomy tube change by 2 nurses without a doctor in patient’s home. Her interest is in education and training in the community. She is committed to improve the knowledge and skills of professional and non-professional caregivers in long term ventilation.
Asst Prof. Angela Takano is a Senior Consultant with the Department of Anatomical Pathology at Singapore General Hospital.
She completed her pathology training in the United States of America at Beth Israel-Deaconess Hospital, followed fellowships in Surgical Pathology and Cytopathology Fellowship at Harford Hospital in Connecticut, and Oncologic Pathology Fellowship at Memorial Sloan-Kettering Cancer Center in New York City.
She dedicates to clinical work in general pathology, pulmonary pathology and cytopathology, as well as teaching medical students and residents and collaborating in lung cancer research with the Lung Cancer Consortium of Singapore.
Dr Tam is Senior Consultant and founding Head of Thoracic Surgery at the National University Heart Centre, Singapore. He is also an Associate Professor of Surgery at the National University of Singapore Yong Loo Lin School of Medicine. He obtained the Bachelor of Science in Biochemistry with First Class Honours (BSc Hon) and Doctor of Medicine (M.D.) degree at the University of Alberta, Canada, and underwent Thoracic Surgery residency training at the University of Manitoba in Canada. He also earned the Master of Education and Master of Science degrees from the University of Manitoba in Canada. He is a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCSC). He was a Clinical Instructor at the Advance Minimally Invasive Thoracic Surgery Centre at the University of Pittsburgh in USA.
Dr Tam specialises in performing advanced minimally invasive surgery using single-port techniques with Uniportal Video-Assisted Thoracoscopic Surgery (UVATS). He was an early pioneer in UVATS lobectomy, performing the first UVATS lobectomy in 2009. He is a champion of enhanced recovery protocols and opioid free analgesia to maximise patients’ comfort, well-being and quality of life after surgery. He leads a high-performance team of thoracic surgeons with excellent surgical outcomes and is passionate with educating the next generations of thoracic surgeons in Singapore and Asia.
Dr Tam specializes in translational clinical research encompassing two domains. The first is applied surgical science in the clinical domain, which includes minimally invasive techniques, enhanced recovery protocols, opioid free analgesia, pain reduction techniques, surgical devices and pneumo-static sealants. The second domain is translation of basic scientific research to clinical applications, which includes mapping of specialise cells in the lung, extracellular vesicles, exosomes, miRNA, and liquid biopsies for early lung cancer detection. He has many research publications in top high-impact international-refereed journals, including Science, Nature, Cell, Immunity, New England Journal of Medicine, Annals of Thoracic Surgery and other top journals in the field of Thoracic Surgery.
Dr Tam is a passionate educator, accomplished faculty developer, and esteemed academic leader. He is currently the Chairman of the Cardio-Thoracic Surgery Residency Advisory Committee at the Ministry of Health, Singapore. He is the Chair of the Multi-disciplinary Lung and Thoracic Cancer Programme at the National Cancer Institute, Singapore. He holds numerous leadership roles and administrative appointments, and has won multiple awards in clinical excellence, research, and education.
Clin A/P (Dr) Tan has been a Family Physician cum senior consultant for the past 15 years. He is a Fellow with the College of Family Physicians Singapore and Academy of Medicine who graduated as one of the six pioneer group of clinicians in the Master in Clinical Investigations in NUS. Since his appointment as Director of Research in SHP in 2012, A/P Tan has been coaching medical and nursing undergraduates, Family Medicine Residents and Family Physicians in Family Medicine Research. His research interests focus on improving person-centred care via technology and innovation. A/P Tan is also the recipient of the Humanity Award in 2006 for research relating to SARS, SingHealth Excellence Award for Clinician in 2012. He is the first family physician to receive the NMRC Clinician Innovator Development Award in 2019 to develop a novel internet of thing system to promote smoking cessation. Recent awards received are NMRC Clinician Innovators Development Award (CIDA) in 2020, Singapore Public Administration Bronze Medal (Pingat Pentadbiran Awam Gansa) in 2021, Singapore Health Quality Service Superstar Merit Award in 2022 and Duke NUS Master Academic Clinician award in 2022. He has published more than 120 papers in peer-reviewed journals and received awards for oral and poster presentations at various WONCA and Family Medicine Conferences.
Dr Tan Geak Poh is a consultant respiratory physician who is currently practicing at the Department of Respiratory & Critical Care Medicine, Tan Tock Seng Hospital. Dr Tan’s main interest is in the field of clinical pulmonary physiology and sleep medicine. Dr Tan completed a fellowship in advanced pulmonary function testing, sleep and non-invasive ventilation at the Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Australia. He leads the TTSH Respiratory Function Laboratory since 2017 and initiated new services including impulse oscillometry and cardiopulmonary exercise testing. He is actively involved in laboratory quality improvement projects and multi-center research in the validation of spirometry reference equations. He is a Fellow at the Academy of Medicine Singapore and Royal College of Physicians Edinburgh.
Dr Tan Shera is a respiratory physician and intensivist with special interest in Tuberculosis and Nontuberculous Mycobacteria. She is currently the clinical director of the TB Control Unit. Dr Shera received her training at National Jewish Health in Denver, USA. She is heavily involved in the clinical care of TB patients, including those with Multi-drug Resistant TB, as well patients with complex non tuberculous mycobacteria diseases due to underlying immunodeficiency.
Dr. Tan Yi Hern completed his medical education in Singapore and graduated from National University of Singapore, Yong Loo Lin School of Medicine in 2011. He completed Singhealth Respiratory Medicine Senior Residency in 2019 and Advanced Specialist Training in Intensive Care Medicine in 2020. He is part of the Interstitial Lung Disease team at Singapore General Hospital and his other interests include pulmonary infections in immunocompromised hosts as well as intensive care.
Augustine Tee is Deputy Chairman Medical Board (Medical Disciplines) and Senior Consultant Respiratory Physician & Intensivist at Changi General Hospital, Singapore. He is an Adjunct Associate Professor with SingHealth Duke-NUS, Lee Kong Chian School of Medicine, and Yong Loo Lin School of Medicine in Singapore. Dr Tee has been engaged in leading roles at various Respiratory professional bodies such as the Chapter of Respiratory Physicians, Singapore Thoracic Society, Asthma & Allergy Association, Society of Intensive Care Medicine, and Residency Advisory Committees at both Respiratory Medicine and Internal Medicine, where he is also an examiner for the specialist exit exams. He is the ex-Co-chair of the Ministry of Health (MOH) COPD Service Improvement Team and member of the MOH Agency for Care Effectiveness expert group on the Appropriate Care Guides for COPD diagnosis.
Conjoint Associate Professor ARTHUR TENG is a senior staff specialist paediatrician, sleep physician and Head of the Department of Sleep Medicine at the Sydney Children’s Hospital, Randwick. Currently he is Conjoint Associate Professor of Medicine at the University of New South Wales (UNSW) and Clinical Senior Lecturer at the University of Tasmania. He was Respiratory Fellow and Chief Resident at the then Prince of Wales Children’s Hospital before training with Professor Colin Sullivan at the David Read Laboratories, University of Sydney, about ten years following the invention of CPAP. His clinical and research interests include the neuropsychological impact of sleep disorders in children, parasomnias, infantile obstructive sleep apnoea and childhood narcolepsy. He has published across the broad spectrum of paediatric sleep disorders in peer-reviewed journals including Sleep, J Applied Physiology, AJRCCM, ERJ, Sleep Medicine, J of Sleep Research, Respirology etc, and several text book chapters. He has supervised and is currently supervising Honours, Masters and PhD Projects through the Universities of Sydney and NSW. He has trained over 20 scientists, paediatric sleep, and respiratory physicians, from Australia and around the world including New Zealand, Hong Kong, China, Malaysia, Singapore, UK, India, Canada, Taiwan and Brazil.
Prof Bruce Thompson AM
B.App.Sci, CRFS, FANZSRS, FAPSR, FThorSoc, Phd
Head of Melbourne School of Health Sciences, University of Melbourne
Professor Bruce Thompson is an active clinical scientist, with over 30 years of experience working in hospitals, universities, the community sector and business. He is a key opinion leader in respiratory medicine nationally and internationally and sits on numerous national and international scientific and clinical committees, and boards for the profession, non-government and not for profit organisations, and industry.
He is a past president of the Thoracic Society of Australia and New Zealand. Prof Thompson developed an international reputation in pulmonary gas exchange physiology early in his career whilst doing his PhD in conjunction with the NASA physiology laboratory at the University of California San Diego. For the first 27 years of is career, he worked in clinical respiratory and sleep laboratories in major teaching hospitals. Throughout this time, he has developed and focused his research on the physiology of small airway function. The work is being approached on a number of fronts including physiology measurement, imaging, and mathematical modelling. Since that time Prof Thompson is now regarded as an international expert on clinical respiratory measurement. His published works include a book on lung function, as well as numerous book chapters and 165 peer-reviewed journal articles and official documents. As an established clinical researcher in lung function, asthma, allergies and respiratory health, Bruce has been awarded competitive grants of over $35.9M including NHMRC and ARC schemes. He is a past President of the Thoracic Society of Australia and New Zealand and was the first non-medical president in the history of the society, and is a Fellow of Australian and New Zealand Society of Respiratory Science, Thoracic Society of Australia and New Zealand and finally Asia Pacific Society of Respirology. He has extensive international reputation across medicine (respiratory and cardiovascular) and biomedical engineering. His international reputation has led to him being invited to participate on five American Thoracic Society/European Respiratory Society task forces and is currently a co-chair of the ATS/ERS task force writing the Lung Function interpretation document which is to be used across all lung function laboratories globally. Prof Thompson’s strengths is bringing non-traditional expertise to clinical healthcare and biomedicine, using his varied contacts and expertise to build truly cross-disciplinary projects.
Marko Topalović, PhD is a CEO of ArtiQ (Leuven, Belgium), an artificial intelligence (AI)-based software company that aims to become the trusted partner of medical practitioners for diagnosis, treatment, and follow-up of respiratory problems.
Prior to co-founding the ArtiQ (University spin-off), as a postdoctoral researcher in the University Hospital in Leuven, Marko worked on improving and developing machine learning algorithms for diagnosing lung diseases. Marko obtained a PhD degree on the topic “Artificial intelligence for pulmonary function tests” in the Laboratory for respiratory disease, at the prestigious KU Leuven (Belgium). With an MSc in Computer Sciences, he continually tries to connect two fields with a goal to augment healthcare using state-of-the-art technology. His scientific work has contributed to many peer-reviewed publications and numerous conference presentations. Moreover, he received international awards on several different occasions. Marko earned his business education from the Flanders Business School (Belgium).
Associate Professor Lauren Troy is a senior staff specialist in Respiratory Medicine at Royal Prince Alfred, Camperdown, Sydney, affiliated with the Central Clinical School, Sydney Medicine, University of Sydney, and Co-Director of the RPA Institute for Academic Medicine. She has clinical and research interests in interstitial lung disease, interventional pulmonology, and lung cancer. She was the principal investigator of the “COLDICE Study”, informing international guidelines on the role of transbronchial lung cryobiopsy in ILD diagnosis, and is an investigator on the Australian NHMRC Centre for Research Excellence in “Interstitial Lung Disease – towards individualised care” program.
Dr. Hao-Chien Wang is professor of Internal medicine in College of Medicine National Taiwan University and consultant physician in Chest specialty practicing at National Taiwan University Hospital in Taipei city. Now he is the chairman of Taiwan Society of Pulmonary & Critical Medicine since 2020. He also is the deputy head of COPD assembly of APSR.
Dr. Wang has an outstanding career marked by contributions to academic research, education, training and clinical practice. Dr. Wang’s research focuses mainly on basic and clinical researches on obstructive airway diseases, acute lung injury and chest ultrasonography in diagnosing of pulmonary diseases,. He has published more than 100 papers in national and international peer reviewed journals. Furthermore, Dr. Wang is an investigator for several ongoing global clinical studies in the area of respiratory disease including pneumonia, COPD & asthma.
Peter Wark is the Director of Cystic Fibrosis and RES2, AIRMED, Alfred Health, Melbourne. He is a conjoint Professor of Medicine at Monash University. He holds an honorary position as a senior staff specialist in Respiratory and Sleep Medicine at John Hunter Hospital, Newcastle and is an adjunct Professor with the University of Newcastle and senior affiliate researcher at the Hunter Medical Research Institute (HMRI) Immune Health Research programme at HMRI.
His research interests are; airway inflammation in the context of chronic airways disease, innate immunity, the role of infection in chronic airways disease and translational clinical trial design. His group has developed expertise in identifying respiratory viruses in airway secretions and developing an in-vitro cell culture model of the airway epithelium that we use to model the effect of infection and inflammation. His research focuses upon factors that increase susceptibility to virus infection in asthma, COPD, Cystic Fibrosis and bronchiectasis. Characterising airway inflammation and innate immune responses in chronic airways disease and applying this to clinical care, as well as the development of precise individualised management strategies.
He is currently on the board of directors for Cystic Fibrosis Australia and the National Asthma Council.
Wisia Wedzicha is Professor of Respiratory Medicine, Head of the Respiratory Division at the National Heart and Lung Institute, Imperial College and Honorary Consultant at Royal Brompton and Harefield Hospitals. She qualified from Somerville College, Oxford University and St Bartholomew’s Hospital Medical College. She was elected as Fellow of the Academy of Medical Sciences (FMedSci) and is a fellow both of the American Thoracic Society (ATSF) and European Respiratory Society (FERS). She received the Helmholtz International Fellow Award in 2014.
Professor Wedzicha has a major interest in the causes, mechanisms, impact and prevention of chronic obstructive pulmonary disease (COPD) exacerbations, and in the role of bacterial and viral infection in COPD exacerbations. She directs an active research group specialising in COPD exacerbations, and has published extensively on this topic.
Professor Wedzicha was Editor-in-Chief of Thorax from 2002 to 2010 and is currently Editor in Chief for the American Journal of Respiratory and Critical Care Medicine. She was the Lancet Ombudsman till 2014, Publications Director for the European Respiratory Society (ERS) and has also previously been ERS Guidelines Director.
Athol Wells, MD, is a Professor of Respiratory Medicine at the Royal Brompton Hospital and Imperial College, London. He trained in New Zealand, moving to the Royal Brompton Hospital in 1999, heading the ILD Unit from 2007 to 2016 and continuing to chair the ILD research group. His research interests include the applicability of CT in ILD diagnosis and prognostic evaluation, patterns of progression in individual ILDs. He created and developed the ILD disease behaviour classification. He received the ERS lifetime achievement in ILD in 2019 and the ERS Presidential Award in 2023. He is a member of the Fleischner Society and current president of the World Association of Sarcoidosis and other Granulomatous Diseases (WASOG). He is one of the most cited world researchers in ILD. In September 2023, his h-index in the Google Scholar Citations database was 151 (101 since 2018), with over 90,000 citations in total.
Sophie West is a respiratory consultant in Newcastle upon Tyne and lead of the Regional Sleep Service. Her clinical and research interests are in best treatments for Obstructive Sleep Apnoea and its associated conditions. She was a committee member for the NICE NG202 Obstructive Sleep Apnoea-Hypopnoea Syndrome and Obesity Hypoventilation Syndrome Guideline, and now sits on the NICE Diagnostics Advisory Committee reviewing Automated home testing devices for diagnosing obstructive sleep apnoea/hypopnoea syndrome.
She authored the Oxford Handbook of Respiratory Medicine for the first three editions.
She is a member of the British Thoracic Society Executive Council and Workforce Committee since 2021.
She is Chair of the Cardiothoracic Board, Newcastle upon Tyne Hospitals
Professor W.S. Fred Wong received his PhD in Pharmacology from the Ohio State University in Columbus, Ohio. He did his postdoctoral training in the Lilly Research Laboratories at Indianapolis and in the Respiratory and Critical Care Medicine Division at the Brigham and Women’s Hospital in Boston. Professor Wong joined the Department of Pharmacology at The National University of Singapore (NUS) in 1995 and since built the Respiratory Pharmacology Laboratory. His research interest is to identify therapeutic targets and to discover and develop novel drug molecules for the treatment of chronic airway inflammation including asthma, COPD and pulmonary fibrosis. Professor Wong was ranked top 2% of scientists worldwide in 2022.
Pan-Chyr Yang, MD, PhD National Taiwan University College of Medicine and National Taiwan University Hospital, Institute of Biomedical Sciences, Genomics Research Center, Academia Sinica, Taiwan.
Dr. Yang is Chair Professor of National Taiwan University. He is former president of National Taiwan University and member of Academia Sinica, World Academic of Science and the National Academy of Inventors. His research interests are lung cancer genomics and precision cancer therapy. He is actively involved in developing novel strategies, including multi-omics, aptamer, nanotechnology and siRNA to improve diagnosis and therapy for cancer and infectious diseases, including COVID-19. His team recently by proteogenomics revealed distinct genetic and environmental signatures of lung cancer pathogenesis and progression in never-smokers. He received the 2020 IASLC Joseph W. Cullen Distinguished Award because of the contributions in leading the lung cancer screening and improving the survival of lung cancer patients.
Dr. Kim Hoong Yap is a senior consultant respiratory physician. He completed his advanced specialist training in Respiratory Medicine in 2012 in Singapore. This was followed by sub-specialty fellowship training in pleural disorders, thoracoscopy and endobronchial ultrasonography in Sir Charles Gairdner Hospital, Perth, Australia in 2014. He was also a fellow in interventional pulmonology in Siriraj Hospital, Bangkok, Thailand in 2016. He currently leads the Pleural Service in Tan Tock Seng Hospital, Singapore. He holds a position of Clinical Senior Lecturer in Yong Loo Lin, School of Medicine, National University Singapore and Faculty Member of the National Healthcare Group (NHG) Respiratory Medicine Residency Program. His interests include pleural infections, thoracoscopy and lung cancer diagnostics.
Respiratory physician and working as the professor of Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, located in the northeast of Kyushu island in Japan.
Specialized clinical fields are general respiratory medicine, occupational lung disease including pneumoconiosis and occupational asthma, obstructive lung disease (asthma and COPD), interstitial lung diseases and respiratory infections.
Research interests focus on the occupational and environmental pollution exposure on respiratory health and diseases, and also bacterial, mycobacterial and viral respiratory pathogens in acute and chronic lower respiratory tract infections such as bacterial/viral pneumonia, nontuberculous mycobacteriosis and bronchiectasis.
It is my great pleasure to work as the Chairperson of the Central Congress Committee and Head-elect of the Environmental & Occupational Health and epidemiology (EOHE) assembly in APSR.
Professor Brendon Yee is a senior staff specialist in Respiratory and Sleep Medicine at Royal Prince Alfred Hospital, Camperdown, Sydney, affiliated with Central Clinical School, Sydney Medicine, University of Sydney. He is the Head, Discipline of Sleep Medicine, Sydney University. He is a Senior Researcher in the Sleep Research Group at the Woolcock Institute of Medical Research. He has a broad clinical and research intertest in both respiratory and non-respiratory sleep disorders and respiratory failure.
He is a current (and previous) investigator in a number of NHMRC grants, NHMRC Centre of Excellence and MRFF grants. He has published extensively (over 140 publications) in peer reviewed journals and textbooks.
He has trained and mentored many adult sleep medicine fellows/physicians from Australasia, Asia and Europe.
He was the previous Chair of the Professional Standards Committee at the Thoracic Society of Australia and New Zealand (TSANZ). He currently serves on the clinical committee in the Australasian Sleep Association (ASA). He is part of the International Sleep Research Training Program for the World Sleep Society.
Dr Chan Yeow graduated from National University of Singapore , Faculty of Medicine ( now known as Yong Lu Lin School of Medicine) in 1994 . He completed Anaesthesiology training in 2003. He underwent a fellowship in Intensive Care Medicine in Melbourne, Victoria in 2004 ( at both the Austin and Repatriation Medical Centre, and The Alfred). He obtained the European Diploma of Intensive Care in 2006.
In 2009, he was appointed the Director of the Home Ventilator Service, which was renamed the Home Ventilation and Respiratory Support Service subsequently. This service currently receives mainstream MOH funding, and is the only de facto adult complex home ventilation service in Singapore.
The HVRSS team underwent a team fellowship in Paris ( L’Hopital Pitie-Salpetriere) and Paris ( the Royal Brompton Hospital) in 2010. The team has hosted numerous visiting experts, and has conducted courses in chronic ventilation locally and in the region.
The HVRSS team currently looks after more than a hundred and eighty complex ventilation users, and has cumulatively looked after more than four hundred ventilation users. In 2022, the team was awarded the Service Delivery Excellence Award of the Public Sector Transformation Awards 2022.
Dr Chan Yeow is interested in philosophy, history and traditional martial arts. He practices Goju Ryu Karate and Taizuquan. He also plays the Erhu.
Dr. Yoshida is a graduate from Mie University School of Medicine (MD) in Japan. His graduate research training (PhD) was completed in Osaka where he demonstrated lung injury resulting from strong spontaneous effort during mechanical ventilation. He furthered this during a year’s work with Dr. Amato (University of São Paulo) where he described ‘Pendelluft’, a new mechanism of effort-dependent lung injury, and developed extensive knowledge of pleural pressure mechanics. He has completed an additional 3-year post-doctoral fellowship in Toronto (Drs. Kavanagh and Brochard) exploring translational research on pleural pressure and its manipulation. Dr. Yoshida has won multiple hospital, university and international awards, most recently the ‘Global Rising Star’ award from the Australian and New Zealand Intensive Care Society. He has taken up a faculty position in Osaka University Graduate School of Medicine (July 2018). Ultimately, Dr. Yoshida pursues translational research towards helping critically ill patients with acute lung disease
Assoc Prof. Barnaby Edward Young is a Senior Consultant at the National Centre for Infectious Diseases in Singapore. He holds a Ph.D. from Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, where he investigated influenza vaccination strategies in the tropics.
At NCID he has contributed significantly to the understanding of COVID-19 through epidemiological and clinical characterization studies. He has published extensively on COVID-19, including studies on viral dynamics, immune responses, and treatment outcomes. With Dr Darius Beh he runs the Long COVID clinic at NCID which was established in November 2021. A/Prof. Young has also been involved in research related to influenza and pneumonia in tropical regions, aiming to improve year-round protection against influenza in older adults. His work includes clinical trials, systematic reviews, and investigations into vaccine effectiveness and immune responses.
In recognition of his research contributions, A/Prof. Young has received the National Medical Research Council Clinician Scientist Award, and the Public Administration Medal (Bronze) for his work during the COVID-19 pandemic.